Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Theravance Biopharma R&D IP LLC | 170 |
| 2 | Innoviva Inc | 104 |
| 3 | MedImmune LLC | 84 |
| 4 | Glaxo Group Ltd | 63 |
| 5 | Cydex Pharmaceuticals Inc | 44 |
| 6 | Encysive Pharmaceuticals Inc | 36 |
| 7 | Chase Pharmaceuticals Corp | 31 |
| 8 | Merck Sharp & Dohme LLC | 30 |
| 9 | PTC Therapeutics Inc | 28 |
| 10 | Stemline Therapeutics Inc | 26 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 1,184 |
| 2 | A61K | Medicinal preparations | 1,017 |
| 3 | C07D | Heterocyclic compounds | 595 |
| 4 | C07K | Peptides | 212 |
| 5 | A61M | Devices for introducing media into the body | 110 |
| 6 | C12N | Microorganisms, enzymes | 105 |
| 7 | C07C | Acyclic and carbocyclic compounds | 80 |
| 8 | G01N | Investigating / analysing materials | 80 |
| 9 | Y02A | Climate change adaptation | 80 |
| 10 | C08L | Polymer compositions (blends) | 69 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Nejiyamas Ekomine Neji | 1983 | ROCKFORD HEADED PRODUCTS | 0 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Neuroscience of respiration and sleep | 2 |
| 2 | Epilepsy research and treatment | 1 |
| 3 | Heart Rate Variability and Autonomic Control | 1 |
| 4 | MicroRNA in disease regulation | 1 |
| 5 | Neuroscience and Neuropharmacology Research | 1 |
| 6 | Receptor Mechanisms and Signaling | 1 |
| 7 | Veterinary Pharmacology and Anesthesia | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Bo Åhrén | Lund University | 8 |
| 2 | David H. Overstreet | University of California, Los Angeles | 6 |
| 3 | Hugo Celso Dutra de Souza | Universidade de São Paulo | 6 |
| 4 | Anton Simeonov | National Center for Advancing Translational Sciences | 5 |
| 5 | Hélio César Salgado | Universidade de São Paulo | 5 |
| 6 | Ajit Jadhav | National Center for Advancing Translational Sciences | 4 |
| 7 | Cândido Celso Coimbra | Universidade Federal de Minas Gerais | 4 |
| 8 | Daniel Tucker | Performance Communications | 4 |
| 9 | Jeffrey M. Witkin | Walter Reed Army Institute of Research | 4 |
| 10 | John R. Martin | A.T. Still University | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Role of the Parasympathetic System in Airway Obstruction Due to Emphysema | 1984 | 262 | Asthma and respiratory diseases |
| Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect | 1983 | 134 | Gastrointestinal motility and disorders |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition and structure of Ekomine?
Which organizations hold the most patents related to Ekomine?
What are the primary research areas and patent classifications associated with Ekomine?
What are the key published research papers on Ekomine?
How has patent and research activity for Ekomine trended in recent years?